MedTrace Logo

Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer

NCT00959023 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 21000

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify genes related to cancer.

PURPOSE: This clinical trial is studying blood and tumor samples from men with an inherited risk of prostate cancer.

Conditions

Interventions

OTHER

laboratory biomarker analysis

OTHER

medical chart review

OTHER

questionnaire administration

Sponsors & Collaborators

  • Institute of Cancer Research, United Kingdom

    lead OTHER

Principal Investigators

  • Rosalind Eeles, PhD, FRCR, FRCP, FMed Sci · Royal Marsden NHS Foundation Trust

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00959023 on ClinicalTrials.gov